Vessella RL - Search Results

1

Inhibition of angiopoietin-2 in LuCaP 23.1 prostate cancer tumors decreases tumor growth and viability.

Morrissey C, Dowell A, Koreckij TD, Nguyen H, Lakely B, Fanslow WC, True LD, Corey E, Vessella RL. Morrissey C, et al. Among authors: vessella rl. Prostate. 2010 Dec 1;70(16):1799-808. doi: 10.1002/pros.21216. Prostate. 2010. PMID: 20583134 Free PMC article.

2

Establishment and characterization of osseous prostate cancer models: intra-tibial injection of human prostate cancer cells.

Corey E, Quinn JE, Bladou F, Brown LG, Roudier MP, Brown JM, Buhler KR, Vessella RL. Corey E, et al. Among authors: vessella rl. Prostate. 2002 Jun 1;52(1):20-33. doi: 10.1002/pros.10091. Prostate. 2002. PMID: 11992617

3

Molecular characterization of prostatic small-cell neuroendocrine carcinoma.

Clegg N, Ferguson C, True LD, Arnold H, Moorman A, Quinn JE, Vessella RL, Nelson PS. Clegg N, et al. Among authors: vessella rl. Prostate. 2003 Apr 1;55(1):55-64. doi: 10.1002/pros.10217. Prostate. 2003. PMID: 12640661

4

LuCaP 35: a new model of prostate cancer progression to androgen independence.

Corey E, Quinn JE, Buhler KR, Nelson PS, Macoska JA, True LD, Vessella RL. Corey E, et al. Among authors: vessella rl. Prostate. 2003 Jun 1;55(4):239-46. doi: 10.1002/pros.10198. Prostate. 2003. PMID: 12712403

5

A novel method of generating prostate cancer metastases from orthotopic implants.

Corey E, Quinn JE, Vessella RL. Corey E, et al. Among authors: vessella rl. Prostate. 2003 Jul 1;56(2):110-4. doi: 10.1002/pros.10235. Prostate. 2003. PMID: 12746835

6

Prostate cancer expression of runt-domain transcription factor Runx2, a key regulator of osteoblast differentiation and function.

Brubaker KD, Vessella RL, Brown LG, Corey E. Brubaker KD, et al. Among authors: vessella rl. Prostate. 2003 Jun 15;56(1):13-22. doi: 10.1002/pros.10233. Prostate. 2003. PMID: 12746842

7

Overexpression of protease-activated receptors-1,-2, and-4 (PAR-1, -2, and -4) in prostate cancer.

Black PC, Mize GJ, Karlin P, Greenberg DL, Hawley SJ, True LD, Vessella RL, Takayama TK. Black PC, et al. Among authors: vessella rl. Prostate. 2007 May 15;67(7):743-56. doi: 10.1002/pros.20503. Prostate. 2007. PMID: 17373694

8

The role of tumor microenvironment in prostate cancer bone metastasis.

Morrissey C, Vessella RL. Morrissey C, et al. Among authors: vessella rl. J Cell Biochem. 2007 Jul 1;101(4):873-86. doi: 10.1002/jcb.21214. J Cell Biochem. 2007. PMID: 17387734 Review.

9

RAD001 (Everolimus) inhibits growth of prostate cancer in the bone and the inhibitory effects are increased by combination with docetaxel and zoledronic acid.

Morgan TM, Pitts TE, Gross TS, Poliachik SL, Vessella RL, Corey E. Morgan TM, et al. Among authors: vessella rl. Prostate. 2008 Jun 1;68(8):861-71. doi: 10.1002/pros.20752. Prostate. 2008. PMID: 18361409 Free PMC article.

10

Protease-activated receptor-1 is upregulated in reactive stroma of primary prostate cancer and bone metastasis.

Zhang X, Wang W, True LD, Vessella RL, Takayama TK. Zhang X, et al. Among authors: vessella rl. Prostate. 2009 May 15;69(7):727-36. doi: 10.1002/pros.20920. Prostate. 2009. PMID: 19170048 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

341 results

Search Page

Filters